algorithm
AI-Based Pathology Method Developed to Potentially Uncover Cancers of Unknown Primary Origin
Premium
In a paper published in Nature, Brigham and Women's researchers describe a novel computational pathology method to improve diagnosis and treatment of metastatic cancers.
Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery
Premium
Fresh off a $13 million round of venture capital, the company said it sees global potential in analyzing hereditary conditions.
PreludeDx DCIS Breast Cancer Test Helps Determine Radiation Therapy Benefits, Reduce Overtreatment
Premium
The test uses prognostic markers to group women based on their risk of 10-year recurrence of ductal carcinoma in situ.
Illumina, New York Healthcare Providers, NYGC Partner on Clinical Whole-Genome Sequencing
Weill Cornell Medicine, New York-Presbyterian Hospital, and the New York Genome Center will join Illumina to sequence the genomes of thousands of patients.
Fibronostics Raises $8M in Series A Round
The financing round was led by Asian private investment firm AT Capital and early-stage deep-tech venture capital fund Elev8.vc.
Feb 28, 2020
Nov 25, 2019
A*STAR Spinoff, IMCB Establish Immuno-Oncology Lab
Jan 17, 2019
Apr 2, 2018
Dec 8, 2017
Oct 5, 2017
Cancer MDx Firm Bioarray Genetics Raises $4M
Jul 5, 2017
Highly Accurate Rapid Test for Malaria Developed
Jan 20, 2017